NeuroSense Therapeutics Ltd Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| YORKVILLE ADVISORS GLOBAL, LP | 05/13/2026 | 78.00 K | $58.89 K | -22.00% | 0.31% |
| INDEPENDENT ADVISOR ALLIANCE | 05/12/2026 | 50.00 K | $37.75 K | 100.00% | 0.20% |
| UBS GROUP AG | 05/05/2026 | 49.10 K | $37.07 K | 59.04% | 0.19% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 44.45 K | $33.56 K | -13.77% | 0.17% |
| MEITAV INVESTMENT HOUSE LTD | 04/29/2026 | 40.00 K | $30.20 K | 0.00% | 0.16% |
| JANE STREET GROUP, LLC | 05/12/2026 | 28.67 K | $21.65 K | 100.00% | 0.11% |
| COMMONWEALTH EQUITY SERVICES, LLC | 04/27/2026 | 22.78 K | $17.19 K | 0.00% | 0.09% |
| PNC FINANCIAL SERVICES GROUP, INC. | 05/08/2026 | 21.15 K | $15.97 K | 100.00% | 0.08% |
| PATHSTONE HOLDINGS, LLC | 05/11/2026 | 16.53 K | $12.48 K | 0.00% | 0.06% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 15.87 K | $11.98 K | 0.00% | 0.06% |
| CREATIVE PLANNING | 05/12/2026 | 11.91 K | $8.99 K | 0.00% | 0.05% |
| JONES FINANCIAL COMPANIES LLLP | 05/15/2026 | 1.00 K | $731 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 265 | $200 | -81.79% | 0.00% |
| GTS SECURITIES LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| SQUAREPOINT OPS LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| JESSUP WEALTH MANAGEMENT, INC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
NeuroSense Therapeutics Ltd institutional Ownership - FAQ's
During the previous two years, 16 institutional investors and hedge funds held shares of NeuroSense Therapeutics Ltd. The most heavily invested institutionals were:
Yorkville Advisors Global, LP: 78,000
Independent Advisor Alliance: 50,000
UBS Group AG: 49,096
TWO SIGMA INVESTMENTS, LP: 44,445
MEITAV INVESTMENT HOUSE LTD: 40,000
JANE STREET GROUP, LLC: 28,670
1.49% of NeuroSense Therapeutics Ltd stock is owned by institutional investors.
Institutional investors have bought a total of 379.71 K shares in the last 24 months. This purchase volume represents approximately $318.96 K in transactions.